Skip to main content
Premium Trial:

Request an Annual Quote

Twist Bioscience: Nicolas Barthelemy

Twist Bioscience has appointed Nicolas Barthelemy to its board of directors. Barthelemy has more than 25 years of experience in the life science industry, the company said. Most recently, he served as president and CEO of privately held molecular diagnostics company Biotheranostics. He has also served as president of global commercial operations at Life Technologies (now Thermo Fisher Scientific), and has served in various operational and commercial roles, including as vice president of manufacturing for Biogen. He began his career with Merck as a project engineer in the vaccine division. Barthelemy currently also serves on the board of Repligen, Fluidigm, Biocare Medical, and 908 Devices.

The Scan

Gone, But Now Reconstructed SARS-CoV-2 Genomes

In a preprint, a researcher describes his recovery of viral sequences that had been removed from a common database.

Rare Heart Inflammation Warning

The Food and Drug Administration is adding a warning about links between a rare inflammatory heart condition and two SARS-CoV-2 vaccines, Reuters reports.

Sandwich Sampling

The New York Times sent tuna sandwiches for PCR analysis.

Nature Papers Describe Gut Viruses, New Format for Storing Quantitative Genomic Data, More

In Nature this week: catalog of DNA viruses of the human gut microbiome, new dense depth data dump format to store quantitative genomic data, and more.